Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
The Lancet. Infectious Diseases
|
May 23, 2025
The health impact of identifying a person with tuberculosis through systematic screening
Emily A Kendall, David W Dowdy
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2022
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications
Theresa S Ryckman, David W Dowdy, Emily A Kendall
The Lancet. Respiratory Medicine
|
December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
Emily A Kendall, Anthony T Fojo, David W Dowdy
The Lancet. Respiratory Medicine
|
November 25, 2015
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Emily A Kendall, Mariam O Fofana, David W Dowdy
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 24, 2016
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective
Emily A Kendall, Ted Cohen, Carole D Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 2, 2014
Transforming the fight against tuberculosis: targeting catalysts of transmission
David W Dowdy, Andrew S Azman, Emily A Kendall, et al.
Plos Medicine
|
December 15, 2017
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study
Emily A Kendall, Samuel G Schumacher, Claudia M Denkinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 19, 2023
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates
Parastu Kasaie, Jeff Pennington, Amita Gupta, et al.
Plos One
|
March 9, 2017
MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Emily A Kendall, Andrew S Azman, Frank G Cobelens, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
Trials underestimate the impact of preventive treatment for household contacts exposed to multidrug-resistant tuberculosis: a simulation study
Parastu Kasaie, Jeff Pennington, Amita Gupta, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
The Lancet. Infectious Diseases
|
May 23, 2025
The health impact of identifying a person with tuberculosis through systematic screening
Emily A Kendall, David W Dowdy
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2022
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications
Theresa S Ryckman, David W Dowdy, Emily A Kendall
The Lancet. Respiratory Medicine
|
December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
Emily A Kendall, Anthony T Fojo, David W Dowdy
The Lancet. Respiratory Medicine
|
November 25, 2015
Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis
Emily A Kendall, Mariam O Fofana, David W Dowdy
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 24, 2016
Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective
Emily A Kendall, Ted Cohen, Carole D Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 2, 2014
Transforming the fight against tuberculosis: targeting catalysts of transmission
David W Dowdy, Andrew S Azman, Emily A Kendall, et al.
Plos Medicine
|
December 15, 2017
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study
Emily A Kendall, Samuel G Schumacher, Claudia M Denkinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 19, 2023
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates
Parastu Kasaie, Jeff Pennington, Amita Gupta, et al.
Plos One
|
March 9, 2017
MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
Emily A Kendall, Andrew S Azman, Frank G Cobelens, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
Trials underestimate the impact of preventive treatment for household contacts exposed to multidrug-resistant tuberculosis: a simulation study
Parastu Kasaie, Jeff Pennington, Amita Gupta, et al.
Page
of 8